uploads///hospice _

What Analysts Recommend for Civitas Solutions in March 2018

By

Mar. 13 2018, Updated 3:29 p.m. ET

Company overview

Civitas Solutions (CIVI) is a leading provider of home and community-based health and human services to adults and children with intellectual or developmental disabilities, brain injury, and other catastrophic injuries and illnesses. It also provides services to youth with emotional, behavioral, and medically complex challenges. At the end of December 2017, Civitas Solutions operated in 36 states across the US, serving more than 12,300 individuals in residential settings and more than 19,000 individuals in non-residential settings.

Article continues below advertisement

Analyst recommendations

In March 2018, of the four analysts covering Civitas Solutions, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating. The mean rating for the stock is 1.5 with a target price of $18.75.

Peer ratings

Of the 18 analysts covering Tenet Healthcare (THC) in March 2018, six analysts have given the stock a “buy” or a higher rating, ten analysts have given it a “hold” rating, while two analysts have given it a “sell” rating. The mean rating for the stock is 2.6 with a target price of $22.76.

Of the 24 analysts covering Express Scripts Holding (ESRX) in March 2018, three analysts have given the stock a “strong buy” rating, and seven analysts have given it a “buy” rating. Nine analysts have given the stock a “hold” rating, while five analysts have given it a “sell” or lower rating. The mean rating for the stock is 2.8 with a target price of $84.39.

Of the 25 analysts covering CVS Health (CVS) in March 2018, eight analysts have given the stock a “strong buy” rating, and ten analysts have given it a “buy” rating. Meanwhile, seven analysts have given it a “hold” rating. The mean rating for the stock is 2.0 with a target price of $88.55.

In the next part of the series, we’ll take a look at the industry trends in Civitas Solutions’ target market.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.